LIC AAO/SBI PO Pre Mini Mock-17

Direction: Read the given passage carefully and answer the questions that follow.
Provision of modern healthcare is characterized by two unique features. There is significant information asymmetry between doctors and patients, and often the demand for medical treatment cannot be postponed. The outcome is malpractice, unless healthcare is carefully regulated. The government will take a stab at this with a regulation to end insidious links between pharmaceutical companies and doctors. The proposed regulation, Essential Commodities (Control of Unethical Practices in Marketing of Drugs) Order 2017, is expected to be notified soon. This is a welcome development, particularly in India where patients and their families have to bear most medical expenses.
The proposed regulation prohibits companies from offering doctors cash, gifts and paid vacations. The penalty for violations could range from penalties to temporary suspension of marketing of a drug. Given the intense competition for most drugs, a suspension is unlikely to have an adverse impact on the supply. Stronger steps are needed to discourage unethical practices. Following the ineffectiveness of attempts by MCI to regulate practices of doctors, government has been left with no choice except to create a framework to target and punish companies indulging in unethical marketing behavior.
The efficacy of the new regulation will depend on its design. Thus far, attempts to curb unethical practices have not yielded satisfactory results. In this context, it makes sense to focus regulatory attention on companies as it is easier to make it mandatory for them to disclose more information on marketing expenditure. Other countries have got companies to provide granular details of expenditure on doctors, which is the first step towards introducing transparency in the relationship between doctors and pharmaceutical companies. The proposed regulation therefore is a good step and needs to be complemented by more measures to enhance transparency.
Source: timesofindia.indiatimes.com 

Direction: Read the given passage carefully and answer the questions that follow.
Provision of modern healthcare is characterized by two unique features. There is significant information asymmetry between doctors and patients, and often the demand for medical treatment cannot be postponed. The outcome is malpractice, unless healthcare is carefully regulated. The government will take a stab at this with a regulation to end insidious links between pharmaceutical companies and doctors. The proposed regulation, Essential Commodities (Control of Unethical Practices in Marketing of Drugs) Order 2017, is expected to be notified soon. This is a welcome development, particularly in India where patients and their families have to bear most medical expenses.
The proposed regulation prohibits companies from offering doctors cash, gifts and paid vacations. The penalty for violations could range from penalties to temporary suspension of marketing of a drug. Given the intense competition for most drugs, a suspension is unlikely to have an adverse impact on the supply. Stronger steps are needed to discourage unethical practices. Following the ineffectiveness of attempts by MCI to regulate practices of doctors, government has been left with no choice except to create a framework to target and punish companies indulging in unethical marketing behavior.
The efficacy of the new regulation will depend on its design. Thus far, attempts to curb unethical practices have not yielded satisfactory results. In this context, it makes sense to focus regulatory attention on companies as it is easier to make it mandatory for them to disclose more information on marketing expenditure. Other countries have got companies to provide granular details of expenditure on doctors, which is the first step towards introducing transparency in the relationship between doctors and pharmaceutical companies. The proposed regulation therefore is a good step and needs to be complemented by more measures to enhance transparency.
Source: timesofindia.indiatimes.com 

Direction: Read the given passage carefully and answer the questions that follow.
Provision of modern healthcare is characterized by two unique features. There is significant information asymmetry between doctors and patients, and often the demand for medical treatment cannot be postponed. The outcome is malpractice, unless healthcare is carefully regulated. The government will take a stab at this with a regulation to end insidious links between pharmaceutical companies and doctors. The proposed regulation, Essential Commodities (Control of Unethical Practices in Marketing of Drugs) Order 2017, is expected to be notified soon. This is a welcome development, particularly in India where patients and their families have to bear most medical expenses.
The proposed regulation prohibits companies from offering doctors cash, gifts and paid vacations. The penalty for violations could range from penalties to temporary suspension of marketing of a drug. Given the intense competition for most drugs, a suspension is unlikely to have an adverse impact on the supply. Stronger steps are needed to discourage unethical practices. Following the ineffectiveness of attempts by MCI to regulate practices of doctors, government has been left with no choice except to create a framework to target and punish companies indulging in unethical marketing behavior.
The efficacy of the new regulation will depend on its design. Thus far, attempts to curb unethical practices have not yielded satisfactory results. In this context, it makes sense to focus regulatory attention on companies as it is easier to make it mandatory for them to disclose more information on marketing expenditure. Other countries have got companies to provide granular details of expenditure on doctors, which is the first step towards introducing transparency in the relationship between doctors and pharmaceutical companies. The proposed regulation therefore is a good step and needs to be complemented by more measures to enhance transparency.
Source: timesofindia.indiatimes.com 

Direction: Read the given passage carefully and answer the questions that follow.
Provision of modern healthcare is characterized by two unique features. There is significant information asymmetry between doctors and patients, and often the demand for medical treatment cannot be postponed. The outcome is malpractice, unless healthcare is carefully regulated. The government will take a stab at this with a regulation to end insidious links between pharmaceutical companies and doctors. The proposed regulation, Essential Commodities (Control of Unethical Practices in Marketing of Drugs) Order 2017, is expected to be notified soon. This is a welcome development, particularly in India where patients and their families have to bear most medical expenses.
The proposed regulation prohibits companies from offering doctors cash, gifts and paid vacations. The penalty for violations could range from penalties to temporary suspension of marketing of a drug. Given the intense competition for most drugs, a suspension is unlikely to have an adverse impact on the supply. Stronger steps are needed to discourage unethical practices. Following the ineffectiveness of attempts by MCI to regulate practices of doctors, government has been left with no choice except to create a framework to target and punish companies indulging in unethical marketing behavior.
The efficacy of the new regulation will depend on its design. Thus far, attempts to curb unethical practices have not yielded satisfactory results. In this context, it makes sense to focus regulatory attention on companies as it is easier to make it mandatory for them to disclose more information on marketing expenditure. Other countries have got companies to provide granular details of expenditure on doctors, which is the first step towards introducing transparency in the relationship between doctors and pharmaceutical companies. The proposed regulation therefore is a good step and needs to be complemented by more measures to enhance transparency.
Source: timesofindia.indiatimes.com 

Direction: Read the given passage carefully and answer the questions that follow.
Provision of modern healthcare is characterized by two unique features. There is significant information asymmetry between doctors and patients, and often the demand for medical treatment cannot be postponed. The outcome is malpractice, unless healthcare is carefully regulated. The government will take a stab at this with a regulation to end insidious links between pharmaceutical companies and doctors. The proposed regulation, Essential Commodities (Control of Unethical Practices in Marketing of Drugs) Order 2017, is expected to be notified soon. This is a welcome development, particularly in India where patients and their families have to bear most medical expenses.
The proposed regulation prohibits companies from offering doctors cash, gifts and paid vacations. The penalty for violations could range from penalties to temporary suspension of marketing of a drug. Given the intense competition for most drugs, a suspension is unlikely to have an adverse impact on the supply. Stronger steps are needed to discourage unethical practices. Following the ineffectiveness of attempts by MCI to regulate practices of doctors, government has been left with no choice except to create a framework to target and punish companies indulging in unethical marketing behavior.
The efficacy of the new regulation will depend on its design. Thus far, attempts to curb unethical practices have not yielded satisfactory results. In this context, it makes sense to focus regulatory attention on companies as it is easier to make it mandatory for them to disclose more information on marketing expenditure. Other countries have got companies to provide granular details of expenditure on doctors, which is the first step towards introducing transparency in the relationship between doctors and pharmaceutical companies. The proposed regulation therefore is a good step and needs to be complemented by more measures to enhance transparency.
Source: timesofindia.indiatimes.com